Published in Women's Health Weekly, November 25th, 2004
Elbit Medical Imaging, Ltd., (EMITF) and General Electric (GE) are significant shareholders in InSightec.
According to the U.S. National Institutes of Health (NIH), at least 25% of women suffer from uterine fibroids.
"Many women with fibroids continue to suffer with their symptoms rather than undergo treatment out of concern for the side effects of existing therapies. ExAblate 2000 gives women an important new choice to help reduce...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly